Loading...
Anti-GD2 immunotherapy for neuroblastomas
INTRODUCTION: Current therapeutic approaches for high-risk neuroblastoma (HR-NB) include high-dose chemotherapy, surgery and radiotherapy; interventions that are associated with long and short-term toxicities. Effective immunotherapy holds particular promise for improving survival and quality of lif...
Na minha lista:
| Udgivet i: | Expert Rev Anticancer Ther |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2017
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6082365/ https://ncbi.nlm.nih.gov/pubmed/28780888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/14737140.2017.1364995 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|